Findings

What do systematic reviews say?

330 questions · 337 findings · 33 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 96 · 28.5%GRADE not reported 53 · 15.7%Very low 80 · 23.7%Low 63 · 18.7%Moderate 39 · 11.6%High 6 · 1.8%

Intervention not reported

Quality of life ‐ Physical health domain SF‐36 Short form · patients with type 1 diabetes mellitus

1 finding from 1 review

Continuous glucose monitoring systems for type 1 diabetes mellitus 2012 · Cochrane Headline outcomes only
no estimate extracted
1 study · 75 participants
Very low

Intervention not reported

Quality of life ‐ Mental health domain SF‐36 Short form · patients with type 1 diabetes mellitus

1 finding from 1 review

Continuous glucose monitoring systems for type 1 diabetes mellitus 2012 · Cochrane Headline outcomes only
no estimate extracted
1 study · 75 participants
Very low

Intervention not reported

Change in HbA1c (%) · patients with type 1 diabetes mellitus

1 finding from 1 review

Continuous glucose monitoring systems for type 1 diabetes mellitus 2012 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 562 participants
Moderate

Intervention not reported

Diabetic complications · patients with type 1 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring systems for type 1 diabetes mellitus 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Severe hypoglycaemia · patients with type 1 diabetes mellitus

The intervention showed no clear difference in severe hypoglycaemia (low certainty).

1 finding from 1 review

Continuous glucose monitoring systems for type 1 diabetes mellitus 2012 · Cochrane Headline outcomes only
RR 1.05 [0.63, 1.77]
5 studies · 689 participants
Low

Digital technology (TIM) vs standard treatment (TBM)

Adherence to inhaled therapies cMPR · children aged 5 to 16 years

Digital technology (TIM) may leads to higher adherence to the inhaled treatment: compared with standard treatment (TBM) (low certainty).

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
MD 24 [2.95, 45.05]
1 study · 20 participants
Low

Digital technology (TIM) vs standard treatment (TBM)

Treatment burden · children aged 5 to 16 years

The review found no eligible studies for this question.

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Digital technology (TIM) vs standard treatment (TBM)

QoL · children aged 5 to 16 years

The review found no eligible studies for this question.

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Digital technology (TIM) vs standard treatment (TBM)

FEV1 (% predicted): mean change from baseline · children aged 5 to 16 years

Digital technology (TIM) showed no clear difference in FEV1 (mean change from baseline, % predicted) compared with standard treatment (TBM) (low certainty).

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
MD 1
1 study · 20 participants
Low

Digital technology (TIM) vs standard treatment (TBM)

Pulmonary exacerbations · children aged 5 to 16 years

The review found no eligible studies for this question.

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found